Your session is about to expire
← Back to Search
Family Centered Treatment for Behavioral Problems (2018-0568 Trial)
N/A
Waitlist Available
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Must not have
youth with diagnosed developmental delays or other cognitive impairments will be excluded into the randomization process and recruitment into the longitudinal study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year, 2 years, 3 years, 4 years
Awards & highlights
No Placebo-Only Group
Summary
This trial found that, among youth authorized to a Level II or Level III out-of-home placement, those who received FCT had better family functioning and mental/behavioral health outcomes, and lower probabilities of being subject of a child protective services report, entering (or re-entering) foster care, being arrested, being retained in grade, being chronically absent, dropping out of high school, or receiving an out-of-home placement, as compared to those who received such a placement. FCT was also associated with lower cost of care.
Who is the study for?
This trial is for children and youth in North Carolina who have behavioral or mental health issues and are authorized for out-of-home placement. They must have a caregiver and home environment suitable for Family Centered Treatment (FCT) but can't participate if they have developmental delays, current safety concerns at home, or are already receiving in-home mental health services from an FCT provider.
What is being tested?
The study compares the effectiveness of Family Centered Treatment (FCT) with Level II or III Out-of-Home Placements (OHP). It aims to see if FCT leads to better family functioning, fewer legal issues, less school absenteeism, lower chances of foster care entry, and reduced costs compared to OHP.
What are the potential side effects?
Since this trial involves social interventions rather than medical treatments, 'side effects' may include emotional distress due to therapy sessions. However, there aren't typical drug side effects as it's not a pharmaceutical intervention.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have developmental delays or cognitive impairments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year, 2 years, 3 years, 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year, 2 years, 3 years, 4 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Caregiver mental health: Total Problems
Family Functioning: General Functioning
Present Value of FCT compared to Out-of-Home Placement
+1 moreSecondary study objectives
Caregiver mental/Behavioral health: Adaptive Functioning Scales: Education
Caregiver mental/Behavioral health: Adaptive Functioning Scales: Family
Caregiver mental/Behavioral health: Adaptive Functioning Scales: Friends
+53 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment: Family Centered TreatmentExperimental Treatment1 Intervention
Family is offered choice of FCT or Level III out-of-home placement
Group II: Control: Level III Out of Home PlacementActive Control1 Intervention
Family is offered Level III out-of-home placement
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,457 Previous Clinical Trials
2,968,659 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a youth with a supportive caregiver and a stable home.I do not have developmental delays or cognitive impairments.
Research Study Groups:
This trial has the following groups:- Group 1: Control: Level III Out of Home Placement
- Group 2: Treatment: Family Centered Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.